University Of California Davis

Down syndrome remained a significant risk factor for pediatric leukemia, especially acute myeloid leukemia, among a large modern cohort of children, according to a retrospective study published in The Journal of Pediatrics.

Progress toward effective drug therapies is often marked with failure; yet even among a host of difficult-to-treat arthritis conditions, osteoarthritis has received a disproportionate share of therapeutic setbacks and disappointing clinical trials.

Patients with both X-linked hypophosphatemia and tumor-induced osteomalacia can benefit from phosphorus replacement therapy, according to two presentations at the United Rheumatology Spring Virtual conference.

UC Davis Comprehensive Cancer Center has become the newest National Comprehensive Cancer Network member institution.

Shelter-in-place orders at the start of the COVID-19 pandemic in the U.S. appear to be associated with significantly lower rates of common community respiratory viruses, including influenza and rhinovirus.

American Association for Cancer Research announced the 2020-2021 class of FDA-AACR oncology educational fellows.

Novel therapies are providing hope in osteoporosis, but questions surrounding optimal treatment regimens remain, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

For decades, the 5-year survival rate for patients with advanced bladder cancer has remained at about 35%.